Cite
APA Citation
Hofmann, D., Sayasone, S., Sengngam, K., Chongvilay, B., Hattendorf, J., & Keiser, J. (2021). efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial. Lancet infectious diseases, 21(8), 1151–1160. http://access.bl.uk/ark:/81055/vdc_100136721573.0x00001d